Literature DB >> 29129009

IRAK2 is associated with susceptibility to rheumatoid arthritis.

Hana Ben Hassine1, Rim Sghiri2,3, Elyes Chabchoub1, Asma Boumiza1, Foued Slama1, Khadija Baccouche4, Zahid Shakoor5, Adel Almogren5, Christina Mariaselvam6, Ryad Tamouza6, Elyes Bouajina4, Ramzi Zemni1.   

Abstract

This study was performed to investigate the association of the single nucleotide polymorphisms of interleukin-1 receptor-associated kinase 2 (IRAK2) rs3844283 and rs708035 with rheumatoid arthritis (RA). IRAK2 rs3844283 and rs708035genotyping was determined by mutagenically separated PCR with specifically designed primers in a cohort of 222 (30 men, 192 women, mean age 49 years) adult RA patients and 224 matched controls. IRAK2 rs3844283 C allele was detected in 66% of RA patients and 74% of controls. The CC genotype was the most frequent genotype in both RA patients (45.5%) and the controls (56.3%). The G allele was found to be associated with RA susceptibility (OR = 1.47, 95% CI = 1.10-1.96, p = 0.008). The GG genotype was found to be associated with RA in the co-dominant and the dominant models (OR = 2.03, 95% CI = 1.08-3.81, p = 0.042 and OR = 1.54, 95% CI = 1.06-2.23, p = 0.023, respectively). IRAK2 rs708035 was found not to be in the Hardy-Weinberg equilibrium. The hyperfunctional IRAK2 rs708035 A allele was more frequent in RA patients than in controls (69.9 versus 62.2%, respectively, p = 0.015). Moreover, IRAK2 rs708035 and IRAK2 rs3844283 were in linkage disequilibrium and the GA haplotype was significantly more frequent in RA patients than in controls (p = 0.034). This study for the first time ever reports the association of IRAK2 rs3844283, IRAK2 rs708035, and the corresponding haplotypes with RA. Functional studies are recommended to elucidate the risk posed by the GA haplotype for the development of RA.

Entities:  

Keywords:  Anti-cyclic citrullinated peptide antibodies; C-reactive protein; Disease activity score 28; Haplotype construction; IRAK2 rs3844283; IRAK2 rs708035; Joint erosion; Rheumatoid arthritis; Rheumatoid factor; Sharp/van der Heijde score

Mesh:

Substances:

Year:  2017        PMID: 29129009     DOI: 10.1007/s10067-017-3906-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  37 in total

1.  Model-free analysis and permutation tests for allelic associations.

Authors:  J H Zhao; D Curtis; P C Sham
Journal:  Hum Hered       Date:  2000 Mar-Apr       Impact factor: 0.444

2.  Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins.

Authors:  A J MacGregor; H Snieder; A S Rigby; M Koskenvuo; J Kaprio; K Aho; A J Silman
Journal:  Arthritis Rheum       Date:  2000-01

3.  Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.

Authors:  Kenneth M Kaufman; Jian Zhao; Jennifer A Kelly; Travis Hughes; Adam Adler; Elena Sanchez; Joshua O Ojwang; Carl D Langefeld; Julie T Ziegler; Adrienne H Williams; Mary E Comeau; Miranda C Marion; Stuart B Glenn; Rita M Cantor; Jennifer M Grossman; Bevra H Hahn; Yeong Wook Song; Chack-Yung Yu; Judith A James; Joel M Guthridge; Elizabeth E Brown; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Luis M Vilá; Juan-Manuel Anaya; Susan A Boackle; Anne M Stevens; Barry I Freedman; Lindsey A Criswell; Bernardo A Pons Estel; Joo-Hyun Lee; Ji-Seon Lee; Deh-Ming Chang; R Hal A Scofield; Gary S Gilkeson; Joan T Merrill; Timothy B Niewold; Timothy James Vyse; Sang-Cheol Bae; Marta E Alarcón-Riquelme; Chaim O Jacob; Kathy Moser Sivils; Patrick M Gaffney; John B Harley; Amr H Sawalha; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

Review 4.  Regulation of nuclear factor-κB in autoimmunity.

Authors:  Shao-Cong Sun; Jae-Hoon Chang; Jin Jin
Journal:  Trends Immunol       Date:  2013-02-20       Impact factor: 16.687

5.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.

Authors:  M Muzio; J Ni; P Feng; V M Dixit
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 6.  Pharmacogenetics: implications for therapy in rheumatic diseases.

Authors:  Lesley Davila; Prabha Ranganathan
Journal:  Nat Rev Rheumatol       Date:  2011-08-09       Impact factor: 20.543

7.  Micro RNA-146a But Not IRAK1 is Associated with Rheumatoid Arthritis in the Tunisian Population.

Authors:  Hana Ben Hassine; Asma Boumiza; Rim Sghiri; Khadija Baccouche; Imen Boussaid; Ahlem Atig; Zahid Shakoor; Elyes Bouajina; Ramzi Zemni
Journal:  Genet Test Mol Biomarkers       Date:  2017-02

8.  NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.

Authors:  A V Miagkov; D V Kovalenko; C E Brown; J R Didsbury; J P Cogswell; S A Stimpson; A S Baldwin; S S Makarov
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

9.  High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Authors:  Steve Eyre; John Bowes; Dorothée Diogo; Annette Lee; Anne Barton; Paul Martin; Alexandra Zhernakova; Eli Stahl; Sebastien Viatte; Kate McAllister; Christopher I Amos; Leonid Padyukov; Rene E M Toes; Tom W J Huizinga; Cisca Wijmenga; Gosia Trynka; Lude Franke; Harm-Jan Westra; Lars Alfredsson; Xinli Hu; Cynthia Sandor; Paul I W de Bakker; Sonia Davila; Chiea Chuen Khor; Khai Koon Heng; Robert Andrews; Sarah Edkins; Sarah E Hunt; Cordelia Langford; Deborah Symmons; Pat Concannon; Suna Onengut-Gumuscu; Stephen S Rich; Panos Deloukas; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Lisbeth Ärlsetig; Javier Martin; Solbritt Rantapää-Dahlqvist; Robert M Plenge; Soumya Raychaudhuri; Lars Klareskog; Peter K Gregersen; Jane Worthington
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

10.  Genetics of rheumatoid arthritis contributes to biology and drug discovery.

Authors:  Yukinori Okada; Di Wu; Gosia Trynka; Towfique Raj; Chikashi Terao; Katsunori Ikari; Yuta Kochi; Koichiro Ohmura; Akari Suzuki; Shinji Yoshida; Robert R Graham; Arun Manoharan; Ward Ortmann; Tushar Bhangale; Joshua C Denny; Robert J Carroll; Anne E Eyler; Jeffrey D Greenberg; Joel M Kremer; Dimitrios A Pappas; Lei Jiang; Jian Yin; Lingying Ye; Ding-Feng Su; Jian Yang; Gang Xie; Ed Keystone; Harm-Jan Westra; Tõnu Esko; Andres Metspalu; Xuezhong Zhou; Namrata Gupta; Daniel Mirel; Eli A Stahl; Dorothée Diogo; Jing Cui; Katherine Liao; Michael H Guo; Keiko Myouzen; Takahisa Kawaguchi; Marieke J H Coenen; Piet L C M van Riel; Mart A F J van de Laar; Henk-Jan Guchelaar; Tom W J Huizinga; Philippe Dieudé; Xavier Mariette; S Louis Bridges; Alexandra Zhernakova; Rene E M Toes; Paul P Tak; Corinne Miceli-Richard; So-Young Bang; Hye-Soon Lee; Javier Martin; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Solbritt Rantapää-Dahlqvist; Lisbeth Arlestig; Hyon K Choi; Yoichiro Kamatani; Pilar Galan; Mark Lathrop; Steve Eyre; John Bowes; Anne Barton; Niek de Vries; Larry W Moreland; Lindsey A Criswell; Elizabeth W Karlson; Atsuo Taniguchi; Ryo Yamada; Michiaki Kubo; Jun S Liu; Sang-Cheol Bae; Jane Worthington; Leonid Padyukov; Lars Klareskog; Peter K Gregersen; Soumya Raychaudhuri; Barbara E Stranger; Philip L De Jager; Lude Franke; Peter M Visscher; Matthew A Brown; Hisashi Yamanaka; Tsuneyo Mimori; Atsushi Takahashi; Huji Xu; Timothy W Behrens; Katherine A Siminovitch; Shigeki Momohara; Fumihiko Matsuda; Kazuhiko Yamamoto; Robert M Plenge
Journal:  Nature       Date:  2013-12-25       Impact factor: 49.962

View more
  2 in total

1.  Multi-locus SNP analyses of interleukin 1 receptor associated kinases 2 gene polymorphisms with the susceptibility to rheumatoid arthritis.

Authors:  Maham Ghouri; Muhammad Ismail; Syeda Areesha Zaidi; Shafique Rehman; Asadullah Dahani; Saima Saleem; Sitwat Zehra
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

2.  A CD40 variant is associated with systemic bone loss among patients with rheumatoid arthritis.

Authors:  Rim Sghiri; Hana Benhassine; Khadija Baccouche; Meriem Ghozzi; Sarra Jriri; Zahid Shakoor; Adel Almogren; Foued Slama; Nadia Idriss; Zeineb Benlamine; Elyes Bouajina; Ramzi Zemni
Journal:  Clin Rheumatol       Date:  2022-02-02       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.